At day 3, the area of enhanced GFAP-IR covered 29 ± 7% of the HF (Figure 4(i)), which increased slightly by day 38 to reach similar values to those obtained in the NMDA group at this time point. The gene discussed is GFAP; the disease is hydrops fetalis.